Blended Care for the Discontinuation of Benzodiazepine Use

NCT03937180 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 924

Last updated 2022-07-15

No results posted yet for this study

Summary

This study aims to compare two strategies performed by GPs to help patients taking benzodiazepines on a daily basis for at least six months to discontinue their use. The first strategy consists of the usual or standard support provided by the GP, which often starts with a discontinuation advice or letter, the second is blended support where face-to-face consultations with the GP are alternated with web-based self-learning by the patient.

Conditions

  • Benzodiazepine Dependence
  • Benzodiazepine Dependent
  • Benzodiazepine Withdrawal

Interventions

BEHAVIORAL

Blended care

An interactive e-learning programme delivered through a secured web-based platform for patients and general practitioners (GPs), blended with face-to-face contacts between the involved GP and patient.

BEHAVIORAL

Usual care

General practitioners offering usual care are expected to follow the Belgian guidelines as described in the most recent online version of "Anxiety, stress and sleeping problems A toolbox for general practitioners." or "Sleeping pills and sedatives. How to assist your patients in the search for other solutions?" which are both available in French and Dutch.

Sponsors & Collaborators

  • Belgium Health Care Knowledge Centre

    collaborator OTHER_GOV
  • Universiteit Antwerpen

    collaborator OTHER
  • University Ghent

    collaborator OTHER
  • Vrije Universiteit Brussel

    collaborator OTHER
  • Université Libre de Bruxelles

    collaborator OTHER
  • Université de Liège

    collaborator OTHER
  • Kristien Coteur

    lead OTHER

Principal Investigators

  • Catharina Matheï · KU Leuven

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-24
Primary Completion
2021-07-30
Completion
2021-08-02

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03937180 on ClinicalTrials.gov